Biologics Consulting Group, Inc. is the leading regulatory consulting firm in product development and regulatory strategy for Biologics, Drugs, and Medical Devices. For almost 20 years, Biologics Consulting Group has supported clients in the preparation and review of CBER, CDER and CDRH regulatory applications, product development strategies, Quality (or CMC) requirements, pre-clinical and clinical study designs, GLP/GCP/GMP audits, and strategic business planning.
BCG advises a global client base in navigating the dynamic areas of product development and regulatory strategy. We have knowledge and contemporary experience with regulatory pathways and can provide the requisite preclinical, clinical, quality, analytical, manufacturing support to increase your chances for success.
View More Consultants »
Biologics Consulting Group, Inc. (BCG) joins scientists and experts from 80 countries in support of the Scientific Declaration on Polio Eradication , declaring that an end to polio is achievable and endorsing a comprehensive new strategy for a polio-free world by 2018.